We are live on ! Find out more
KURE icon

KraneShares MSCI All China Health Care Index ETF

22 hedge funds and large institutions have $30.6M invested in KraneShares MSCI All China Health Care Index ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2.53% less ownership

Funds ownership: 12.17%9.64% (-2.5%)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

14% less capital invested

Capital invested by funds: $35.5M → $30.6M (-$4.91M)

19% less funds holding

Funds holding: 2722 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
8
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MMFA
1
Main Management Fund Advisors
California
$18.9M +$90.8K +3,700 +8%
OMC
2
Old Mission Capital
Illinois
$2.79M +$2.13M +86,785 +264%
Jane Street
3
Jane Street
New York
$2.44M +$1.42M +57,724 +123%
Morgan Stanley
4
Morgan Stanley
New York
$2.21M -$570K -23,197 -20%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$961K +$213K +8,672 +27%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$956K -$496K -20,186 -33%
KFA
7
Krane Funds Advisors
New York
$697K +$734K +29,906 New
Citadel Advisors
8
Citadel Advisors
Florida
$517K -$546K -22,231 -50%
Goldman Sachs
9
Goldman Sachs
New York
$450K +$475K +19,332 New
BCV
10
Banque Cantonale Vaudoise
Switzerland
$211K +$108K +4,398 +94%
Citigroup
11
Citigroup
New York
$153K +$52.3K +2,132 +48%
Bank of America
12
Bank of America
North Carolina
$134K
UBS Group
13
UBS Group
Switzerland
$106K -$2.61M -106,195 -96%
FP
14
Financial Perspectives
Minnesota
$46.7K +$16.7K +681 +51%
PA
15
Parallel Advisors
California
$15K
NSIM
16
North Star Investment Management
Illinois
$5K
MIFH
17
Migdal Insurance & Financial Holdings
Israel
$3K -$11K -450 -75%
Osaic Holdings
18
Osaic Holdings
Arizona
$1K -$4.74K -193 -87%
AWM
19
Activest Wealth Management
Florida
$1K
BCMLT
20
Beacon Capital Management LLC (Tennessee)
Tennessee
$1K +$1.23K +50 New
MM
21
Main Management
California
-$2.03M -82,772 -100%
CP
22
Castleview Partners
Texas
-$646 -18,540 Closed
OPS
23
Orion Portfolio Solutions
Nebraska
-$285K -9,941 Closed
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
-$92.3K -3,760 -100%
Koshinski Asset Management
25
Koshinski Asset Management
Illinois
-$45.9K -1,600 Closed

KURE Hedge Fund Activity: Q1 2022 in Review

22 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in KraneShares MSCI All China Health Care Index ETF (KURE) for Q1 2022, worth a combined $30.6M — down 14% from $35.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of KURE and 3 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 7 added.

The largest buyer was Old Mission Capital, adding an estimated $2.13M. The largest seller was UBS Group, cutting an estimated $2.61M.

  • 22 institutional investors held KraneShares MSCI All China Health Care Index ETF (KURE) as of Q1 2022, down from 27 in Q4 2021.
  • Funds reported $30.6M of KraneShares MSCI All China Health Care Index ETF stock for Q1 2022, down 14% quarter-over-quarter.
  • 3 funds opened new KraneShares MSCI All China Health Care Index ETF positions in Q1 2022 and 8 closed out, a net change of -5 holders.
  • The largest KraneShares MSCI All China Health Care Index ETF buyer in Q1 2022 was Old Mission Capital, an estimated $2.13M added.
  • The largest KraneShares MSCI All China Health Care Index ETF seller in Q1 2022 was UBS Group, an estimated $2.61M sold.

Based on aggregated 13F filings for Q1 2022.